Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 983-992

  Ricciardelli, Carmela ^a   Mayne, Keiko ^a   Sykes, Pamela J ^a   Raymond, Wendy A ^a   McCaul, Kieran ^b   Marshall, Villis R ^a   Tilley, Wayne D ^a   Skinner, John M ^a   Horsfall, David J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EARLY CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; STROMA; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CELL DIVISION; CHONDROITIN SULFATES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STROMAL CELLS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030917298     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ohori, M., Wheeler, T. M., Dunn, J., K., Stamey, T. A., and Scardino, P. T. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J. Urol., 152: 1714-1720, 1994.
2. Carter, H. B., and Coffey, D. S. The prostate: an increasing medical problem. Prostate, 16: 39-48, 1990.
3. Catalona, W. J., and Basler, J. W. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J. Urol., 150: 905-907, 1993.
4. Murphy, G. P., Mettlin C., Menck, H., Winchester, D. P., and Davidson, A-M. National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer. J. Urol., 152: 1817-1819, 1994.
5. Walsh, P. C., Partin, A. W., and Epstein, J. I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., 152: 1831-1836, 1994.
6. Fowler, F. J., Barry M. J., Lu-Yao, G., Roman, A., Wasson, J., and Wennberg, J. E. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology, 42: 622-629, 1993.
7. Catalona, W. J., and Smith, D. S. 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol., 152: 1837-1842, 1994.
8. Walsh, P. C., Partin, A. W., and Epstein, J. I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., 152: 1831-1836, 1994.
9. 2 tumor. J. Urol., 152: 1799-1805, 1994.
10. Moul, J. W., Maygarden, S. J., Ware, J. L., Mohler, J. L., Maher, P. D., Schenkman, N. S., and Ho, C. K. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy. J. Urol., 155: 982-985, 1996.
11. Bauer, J. J., Sesterhenn, I. A., Mostofi, K. F., McLeod, D. G., Srivastava, S., and Moul, J. W. p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. Clin. Cancer Res., 1: 1295-1300, 1995.
12. Stricker, H. J., Jay, J. K., Linden M. D., Tamboli, P., and Amin, M. B. Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53. Urology, 47: 366-369, 1996.
13. Yang, G., Stapleton A. M., F., Wheeler, T. M., Truong, L. D., Timme, T. L., Scardino, P. T., and Thompson T. C. Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression. Clin. Cancer Res., 2: 399-401, 1996.
14. Umbas, R., Isaacs, W. B., Bringuier P. P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne F. M. J., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994.
15. Donjacour, A., and Cunha, G. Stromal regulation of epithelial function. Cancer Treat. Res., 53: 335-364, 1991.
16. Chung, L. W. K. Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation. Cancer Biol. Semin., 4: 183-192, 1993.
17. Davies, P., and Eaton, C. Regulation of prostatic growth. J. Endocrinol., 131: 5-17, 1991.
18. Story, M. T. Positive and negative modulators of prostate cell proliferation. Biomed. Pharmacother., 48: 35s-41s, 1994.
19. Ruoslahti, E. Proteoglycans in cell regulation. J. Biol. Chem., 264: 13369-13372, 1989.
20. Yayon, A., Klagsbrun, M., Esko, J., D., Leder, P., and Ornitz, D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64: 841-848, 1991.
21. Bernfield, M., and Sanderson, R. D. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Philos. Trans. R. Soc. Lond. B Biol. Sci., 327: 171-186, 1990.
22. Brittis, P. A., Canning, D. R., and Silver, J. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science (Washington DC), 255: 733-736, 1992.
23. Vaino, S., Jalkanen, M., Vaahtokari, A., Sahlberg, C., Marli, M., Bernfield M, and Thesleff, I. Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth morphogenesis. Dev. Biol., 147: 322-333, 1991.
24. Caterson, B., Mahmoodian, F., Sorrell, J. M., Hardingham, T. E., Bayliss, M. T., Carney, S. L., Ratcliffe, A., and Muir, H. Modulation of native chondroitin sulfate structure in tissue development and disease. J. Cell Sci., 97: 411-417, 1990.
25. Adany, R., Heimer, R., Caterson, B., Sorrell, J. M., and Iozzo, R. V. Altered expression of chondroitin sulfate proteoglycan in the stroma of colon cancer. J. Biol. Chem., 265: 11389-11396, 1990.
26. Yeo, T. K., Brown, L., and Dvorak, H. F. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am. J. Pathol., 138: 1437-1450, 1991.
27. Hauptmann, S., Zardi, L., Siri, A., Carnemolla, B., Borsi, L., Castellucci, M., Klosterhalfen, B., Hartung, P., Weis, J., Stocker, G., Haubeck, H-D., and Kirkpatrick, C. J. Extracellular matrix proteins in colorectal carcinomas: expression of tenascin and fibronectin isoforms. Lab. Invest., 73: 172-182, 1995.
28. Cohen, I. R., Murdoch, A. D., Naso, M. F., Marchetti, D., Berd, D., and Iozzo, R. V. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res., 54: 5771-5774, 1994.
29. Inki, P., Larjava, H., Haapasalmi, K., Miettinen, H., Grenman, R., and Jalkanen, M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur. J. Cell Biol., 63: 43-51, 1994.
30. Iozzo, R. V. Tumor stroma as a regulator of neoplastic behavior. Lab. Invest., 73: 157-160, 1995.
31. Inki, P., Joensuu, H., Grenman, R., Klemi, P., and Jalkanen, M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br. J. Cancer, 70: 319-323, 1994.
32. Inki, P., Stenback, F. Grenman, S., and Jalkanen, M. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J. Pathol., 172: 349-355, 1994.
33. Horsfall, D. J., Mayne, K., Ricciardelli, C., Rao, M., Skinner, J. M. S., Henderson, D. W., Marshall, V. R., and Tilley, W. D. Age-related change in guinea pig prostatic stroma. Lab. Invest., 70: 753-763, 1994.
34. Böcking, A., Kiehn, J., and Heinzel-Wach, M. Combined histologic grading of prostatic carcinoma. Cancer (Phila.), 50: 288-294, 1982.
35. Hermanek, P., and Sobin, L. H. International Union against Cancer (UICC). Urological tumours: prostate. In: TNM Classification of Urological Tumours, 4th ed., 2nd revision, p. 141. New York: Springer-Verlag, 1992.
36. Horsfall, D. J., Mayne, K., Skinner, J. M. S., Saccone, G. T. P., Marshall, V. R., and Tilley, W. D. Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate. Prostate, 25: 320-332, 1994.
37. Sorrell, J. M., Mahmoodian, F., Schafer, I. A., Davis, B., and Caterson, B. Identification of monoclonal antibodies that recognize novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains. Their use in mapping functionally distinct domains of human skin. J. Histochem. Cytochem., 38: 393-402, 1990.
38. Iversen, P., Adolfsson, J., Johansson, J. E., and Torp-Pederson, S. Localized prostate cancer - a Scandinavian view. Monogr. Urol., 15: 94-101, 1994.
39. De Klerk, D. P. The glycosaminoglycans of normal and hyperplastic prostate. Prostate, 4: 73-81, 1983.
40. De Klerk, D. P., Lee, D. V., and Human, H. J. Glycosaminoglycans of human prostatic cancer. J. Urol., 131: 1008-1012, 1984.
41. De Klerk, D. P., and Human, H. J. Fluctuations in prostatic glycosaminoglycans during fetal and pubertal growth. Prostate, 6: 169-175, 1985.
42. Chan, L., and Wong, Y. C. Cytochemical characterization of cuprolinic blue-stained proteoglycans in the epithelial-stromal interface of the guinea pig lateral prostate. Prostate, 14: 133-145, 1989.
43. Chan, L., and Wong, Y. C. Ultrastructural localization of proteoglycans by cationic dyes in the epithelial-stromal interface of the guinea pig lateral prostate. Prostate, 14: 147-162, 1989.
44. Kofoed, J. A., Houssay, A. B., Tocci, A. A., Curbelo, H. M., and Gamper, C. H. Effects of testosterone on glycosaminoglycans in the prostate, seminal vesicles and salivary glands of the rat. J. Endocrinol., 51: 465-471, 1971.
45. Kofoed, J. A., Tumilasci, O. R., Curbelo, H. M., Fernandez Lemos S. M., Arias N. H., and Houssay, A. B. Effects of castration and androgens upon prostatic proteoglycans in rats. Prostate, 16: 93-102, 1990.
46. Yamagata, M., Suzuki, S., Akiyama, S. K., Yamada, K. M., and Kimata, K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem., 264: 8012-8018, 1989.